BP
BIOMARIN PHARMACEUTICAL INC.
Organization · CA
Hires government relations
Who they hire
What they lobby on
HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL HR 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL HR 6094: PROVIDING REALISTIC OPPORTUNITY TO EQUAL AND COMPARABLE TREATMENT FOR RARE ACT (PROTECT RARE ACT); ALL PROVISIONS OF THE BILL S 4204: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL S 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES AND ACCESS TO OUT OF STATE PROVIDERS
HR 830: HELP ENSURE LOWER PATIENT COPAYS ACT; ALL PROVISIONS OF THE BILL HR 2369: VERIFYING ACCURATE LEADING-EDGE IVCT DEVELOPMENT ACT OF 2023; ALL PROVISIONS OF THE BILL HR 2630: SAFE STEP ACT; ALL PROVISIONS OF THE BILL HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); PROVISIONS RELATED TO OUTCOME BASED ARRANGEMENTS (OBA) AND VALUE BASED ARRANGEMENTS (VBA) HR 5539: OPTIMIZING RESEARCH PROGRESS HOPE AND NEW CURES ACT (ORPHAN CURES ACT); ALL PROVISIONS OF THE BILL HR 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; ALL PROVISIONS OF THE BILL S 4583: A BILL TO AMEND THE FEDERAL FOOD, DRUG, AND COSMETIC ACT TO EXTEND THE AUTHORITY OF THE SECRETARY OF HEALTH AND HUMAN SERVICES TO ISSUE PRIORITY REVIEW VOUCHERS TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES; ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING HEALTH EQUITY
HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING MEDICAID ACCESS TO RARE DISEASE THERAPIES AND ACCESS TO OUT OF STATE PROVIDERS
HR 2666: MEDICAID VBPS FOR PATIENTS ACT (MVP ACT); PROVISIONS RELATED TO OUTCOME BASED ARRANGEMENTS (OBA) AND VALUE BASED ARRANGEMENTS (VBA) HR 5539: OPTIMIZING RESEARCH PROGRESS HOPE AND NEW CURES ACT (ORPHAN CURES ACT); ALL PROVISIONS OF THE BILL HR 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024: ALL PROVISIONS OF THE BILL HR 7635: THE 340B PHARMACEUTICAL ACCESS TO INVEST IN ESSENTIAL, NEEDED TREATMENTS & SUPPORT ACT OF 2024 (PATIENTS ACT); ALL PROVISIONS OF THE BILL GENERAL DISCUSSIONS REGARDING HEMOPHILIA GENE THERAPY